For muscle phenotypes, clinical studies have hinted at the involvement of insulin signaling in muscle wasting by demonstrating favorable yet preliminary effects on muscle with recombinant IGF1 or metformin in DM1 patients. The gene discussed is IGF1; the disease is myotonic dystrophy type 1.